POM121L inhibitors represent a class of chemical compounds that target the POM121-like (POM121L) protein, which plays a crucial role in the structure and function of the nuclear pore complex (NPC). The NPC is a large multi-protein assembly embedded in the nuclear envelope, acting as a gateway for the regulated exchange of macromolecules between the nucleus and the cytoplasm. POM121L, a transmembrane nucleoporin, is involved in anchoring the nuclear pore to the nuclear envelope, thus ensuring the stability and integrity of the NPC. This protein also contributes to the selective permeability barrier that controls the traffic of RNA, proteins, and other macromolecules. Inhibitors of POM121L interfere with these structural and transport functions by modulating the activity or expression of the protein, potentially altering nuclear-cytoplasmic transport and NPC assembly.
These inhibitors are typically studied in the context of their effects on cellular processes that rely on nuclear-cytoplasmic transport. By disrupting the NPC's structural integrity through POM121L inhibition, cellular processes like gene expression regulation, cell cycle progression, and signal transduction pathways may be influenced. The inhibition of POM121L may also affect the dynamics of chromatin organization and the maintenance of nuclear architecture, given that the NPC is implicated in various genome-related functions. Moreover, studies into POM121L inhibitors often focus on understanding their effects on nuclear pore assembly and the potential impact on cellular homeostasis, which can further elucidate fundamental mechanisms of cell biology, especially regarding nucleocytoplasmic exchange. Through this lens, POM121L inhibitors are important tools for probing the intricacies of nuclear pore function and its relevance to cellular organization.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Actinomycin D inhibits RNA synthesis, potentially impacting the expression of POM121L2 at the transcriptional level. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $88.00 $200.00 | 13 | |
Triptolide inhibits RNA polymerase and NF-κB, potentially affecting the transcription of POM121L2 and its regulatory pathways. | ||||||
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $254.00 | 41 | |
Flavopiridol inhibits cyclin-dependent kinases, potentially affecting the transcriptional regulation of POM121L2 and its associated pathways. | ||||||
Triamcinolone acetonide | 76-25-5 | sc-205872 sc-205872A | 50 mg 250 mg | $56.00 $149.00 | ||
Triamcinolone acetonide is a glucocorticoid receptor agonist, and its modulation of transcriptional activity may impact the expression of POM121L2. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $260.00 $1029.00 | 26 | |
α-Amanitin inhibits RNA polymerase II, potentially impacting the transcription of POM121L2 and its downstream targets. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor, potentially impacting the epigenetic regulation of POM121L2 expression. | ||||||
Ellipticine | 519-23-3 | sc-200878 sc-200878A | 10 mg 50 mg | $142.00 $558.00 | 4 | |
Ellipticine is a DNA-intercalating agent, potentially impacting the transcriptional regulation of POM121L2 and its associated pathways. | ||||||